These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 12177102)

  • 1. Factorial design considerations.
    Green S; Liu PY; O'Sullivan J
    J Clin Oncol; 2002 Aug; 20(16):3424-30. PubMed ID: 12177102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factorial designs: a graphical aid for choosing study designs accounting for interaction.
    Byth K; Gebski V
    Clin Trials; 2004; 1(3):315-25. PubMed ID: 16279257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trial designs for evaluating combination HIV prevention approaches.
    Chen YQ; Peng L; Wang Y; Appelmans E; Dasgupta S; Fleming TR
    HIV Res Clin Pract; 2020; 21(2-3):72-82. PubMed ID: 32698705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-factorial analyses of two-by-two factorial trial designs.
    Korn EL; Freidlin B
    Clin Trials; 2016 Dec; 13(6):651-659. PubMed ID: 27439306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the statistical power for multiple tests: a case study.
    Yeo A; Qu Y
    Pharm Stat; 2009; 8(1):5-11. PubMed ID: 18381588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, analysis and presentation of factorial randomised controlled trials.
    Montgomery AA; Peters TJ; Little P
    BMC Med Res Methodol; 2003 Nov; 3():26. PubMed ID: 14633287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factorial versus multi-arm multi-stage designs for clinical trials with multiple treatments.
    Jaki T; Vasileiou D
    Stat Med; 2017 Feb; 36(4):563-580. PubMed ID: 27804166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bayesian design and analysis of two x two factorial clinical trials.
    Simon R; Freedman LS
    Biometrics; 1997 Jun; 53(2):456-64. PubMed ID: 9192445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization of adaptive designs: efficiency evaluation.
    Menon S; Chang M
    J Biopharm Stat; 2012; 22(4):641-61. PubMed ID: 22651106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A two stage conditional power adaptive design adjusting for treatment by covariate interaction.
    Ayanlowo AO; Redden DT
    Contemp Clin Trials; 2008 May; 29(3):428-38. PubMed ID: 18053774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two-by-Two Factorial Cancer Treatment Trials: Is Sufficient Attention Being Paid to Possible Interactions?
    Freidlin B; Korn EL
    J Natl Cancer Inst; 2017 Sep; 109(9):. PubMed ID: 28954288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resampling in multiple-dose factorial designs.
    Frommolt P; Hellmich M
    Biom J; 2009 Dec; 51(6):915-31. PubMed ID: 20029896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A computer program for sample size and power calculations in the design of multi-arm and factorial clinical trials with survival time endpoints.
    Natarajan R; Turnbull BW; Slate EH; Clark LC
    Comput Methods Programs Biomed; 1996 Mar; 49(2):137-47. PubMed ID: 8735021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A practical limit to trials needed in one-person randomized controlled experiments.
    Alemi R; Alemi F
    Qual Manag Health Care; 2007; 16(2):130-4. PubMed ID: 17426611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Power and sample size when multiple endpoints are considered.
    Senn S; Bretz F
    Pharm Stat; 2007; 6(3):161-70. PubMed ID: 17674404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sample size requirements for separating out the effects of combination treatments: randomised controlled trials of combination therapy vs. standard treatment compared to factorial designs for patients with tuberculous meningitis.
    Wolbers M; Heemskerk D; Chau TT; Yen NT; Caws M; Farrar J; Day J
    Trials; 2011 Feb; 12():26. PubMed ID: 21288326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reporting of randomized factorial trials was frequently inadequate.
    Kahan BC; Tsui M; Jairath V; Scott AM; Altman DG; Beller E; Elbourne D
    J Clin Epidemiol; 2020 Jan; 117():52-59. PubMed ID: 31585174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distributive randomization: a pragmatic fractional factorial design to screen or evaluate multiple simultaneous interventions in a clinical trial.
    Haviari S; Mentré F
    BMC Med Res Methodol; 2024 Mar; 24(1):64. PubMed ID: 38468221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sample size estimation in single-arm clinical trials with multiple testing under frequentist and Bayesian approaches.
    Zaslavsky BG; Scott J
    J Biopharm Stat; 2012; 22(4):819-35. PubMed ID: 22651117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factorial designs: an overview with applications to orthodontic clinical trials.
    Pandis N; Walsh T; Polychronopoulou A; Katsaros C; Eliades T
    Eur J Orthod; 2014 Jun; 36(3):314-20. PubMed ID: 23885023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.